AU8171287A - Oral administration capsule with a nicotine-containing fluid medium - Google Patents
Oral administration capsule with a nicotine-containing fluid mediumInfo
- Publication number
- AU8171287A AU8171287A AU81712/87A AU8171287A AU8171287A AU 8171287 A AU8171287 A AU 8171287A AU 81712/87 A AU81712/87 A AU 81712/87A AU 8171287 A AU8171287 A AU 8171287A AU 8171287 A AU8171287 A AU 8171287A
- Authority
- AU
- Australia
- Prior art keywords
- nicotine
- oral administration
- fluid medium
- capsule
- containing fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Abstract
An oral administration capsule with a nicotine-containing, fluid medium. The capsule can be opened by pressing it with the teeth, the amount of nicotine is between 0.1 and 10 mg, the medium contains additives to improve its flavour and consistency and its pH is between 6 and 10. A capsule is thus obtained that can have various uses, especially to reduce addiction to smoking and to control feelings of hunger.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3639418 | 1986-11-18 | ||
DE19863639418 DE3639418A1 (en) | 1986-11-18 | 1986-11-18 | NICOTINE-BASED AGENT |
Publications (2)
Publication Number | Publication Date |
---|---|
AU8171287A true AU8171287A (en) | 1988-06-16 |
AU622101B2 AU622101B2 (en) | 1992-04-02 |
Family
ID=6314221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU81712/87A Ceased AU622101B2 (en) | 1986-11-18 | 1987-11-06 | Oral administration capsule with a nicotine-containing fluid medium |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0324794B1 (en) |
JP (1) | JP2602043B2 (en) |
CN (1) | CN87107852A (en) |
AT (1) | ATE72114T1 (en) |
AU (1) | AU622101B2 (en) |
BR (1) | BR8707879A (en) |
DE (3) | DE3639418A1 (en) |
DK (1) | DK173353B1 (en) |
WO (1) | WO1988003803A1 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
DE4440563A1 (en) * | 1994-11-12 | 1996-05-15 | Herzog Sen Rolf | Nicotine-contg. media and perfume ointments as substitute for smoking |
US5604231A (en) * | 1995-01-06 | 1997-02-18 | Smith; Carr J. | Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
US5846983A (en) * | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
WO1997034605A1 (en) * | 1996-03-21 | 1997-09-25 | Mayo Foundation For Medical Education And Research | Use of nicotine to treat liver disease |
GB9614902D0 (en) | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
AUPO108596A0 (en) * | 1996-07-18 | 1996-08-08 | Collier, Gregory | Treatment of obesity |
US6211194B1 (en) | 1998-04-30 | 2001-04-03 | Duke University | Solution containing nicotine |
US6268386B1 (en) * | 1998-06-25 | 2001-07-31 | Marshall Anlauf Thompson | Nicotine beverage |
GB2338896B (en) * | 1998-07-02 | 2003-05-21 | Reckitt & Colmann Prod Ltd | Chewable Capsules |
US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
CA2380072C (en) | 1999-07-28 | 2007-07-10 | John Cooke | Nicotine in therapeutic angiogenesis and vasculogenesis |
AT409219B (en) * | 1999-08-13 | 2002-06-25 | Red Bull Gmbh | Use of nicotine for producing pharmaceuticals |
SE0104388D0 (en) * | 2001-12-27 | 2001-12-27 | Pharmacia Ab | New formulation and use and manufacture thereof |
US20040002520A1 (en) * | 2002-07-01 | 2004-01-01 | Soderlund Patrick L. | Composition and method for cessation of Nicotine cravings |
DK3473251T3 (en) | 2002-12-20 | 2024-01-22 | Niconovum Ab | NICOTINE-CELLULOSE COMBINATION |
IL155666A (en) | 2003-04-29 | 2013-12-31 | Neurim Pharma 1991 | Composition for treating insomnia |
US9119846B2 (en) | 2003-04-29 | 2015-09-01 | Neurim Pharmaceuticals (1991) Ltd. | Method and composition for enhancing cognition in alzheimer's patients |
WO2005007068A1 (en) * | 2003-07-22 | 2005-01-27 | The Kiwigel Company Limited | Nicotine packaging system |
NO20042835D0 (en) * | 2004-07-05 | 2004-07-05 | Nils-Erik Skeide | Encapsulated tobacco smoke |
EP1802258A4 (en) | 2004-09-13 | 2015-09-23 | Chrono Therapeutics Inc | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
JP5694645B2 (en) | 2006-03-16 | 2015-04-01 | ニコノヴァム エービーNiconovum Ab | Improved snuff composition |
GB2448224B (en) * | 2007-04-02 | 2010-09-01 | Parkinson S Inst | Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent |
CN101249130B (en) * | 2008-04-11 | 2011-06-15 | 桂林商源植物制品有限公司 | Medicinal or health care combination for stop smoking or alleviating stop smoking syndrome |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
US10213586B2 (en) | 2015-01-28 | 2019-02-26 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
EP3297676A2 (en) * | 2015-05-22 | 2018-03-28 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Combination of trpm8-agonist and nachr-agonist for treatment of obesity and related disorders and for weight reduction |
CN105341990A (en) * | 2015-12-16 | 2016-02-24 | 浙江中烟工业有限责任公司 | Electronic cigarette tobacco juice capable of improving physiological satisfaction of electronic cigarettes |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
CA3101966A1 (en) | 2018-05-29 | 2019-12-05 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU432703A3 (en) * | 1971-08-24 | 1974-06-15 | Фридрих Боссерт, Вульф Фатер, Курт Бауер | |
US3870794A (en) * | 1974-02-20 | 1975-03-11 | Foundation For Behavioral Rese | Treatment of certain emotional disorders with nicotine compounds |
GB1528391A (en) * | 1976-01-05 | 1978-10-11 | Gildemeister V | Aerosol compositions |
DE3241437A1 (en) * | 1982-11-10 | 1984-05-10 | Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt | Composition for stopping smoking and/or for intake of nicotine without side effects by addicted smokers |
GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
BE899037A (en) * | 1984-02-29 | 1984-06-18 | Trenker Ady | Nicotine compsn. to help people to stop smoking - is a tablet for sucking, which contains nicotine or its water-soluble acid salt |
DE3438284A1 (en) * | 1984-10-16 | 1985-03-07 | Hans-Harald von 2400 Lübeck Tilly | Nicotine-containing depot plaster |
EP0186502A3 (en) * | 1984-12-25 | 1986-12-10 | Jano Tyroler | Flavor capsule and method of preparing same |
US4680172A (en) * | 1985-03-05 | 1987-07-14 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
-
1986
- 1986-11-18 DE DE19863639418 patent/DE3639418A1/en active Granted
- 1986-11-18 DE DE19863645036 patent/DE3645036A1/en active Granted
-
1987
- 1987-11-06 BR BR8707879A patent/BR8707879A/en not_active Application Discontinuation
- 1987-11-06 JP JP62506732A patent/JP2602043B2/en not_active Expired - Lifetime
- 1987-11-06 DE DE8787907302T patent/DE3776574D1/en not_active Expired - Fee Related
- 1987-11-06 AU AU81712/87A patent/AU622101B2/en not_active Ceased
- 1987-11-06 AT AT87907302T patent/ATE72114T1/en not_active IP Right Cessation
- 1987-11-06 EP EP87907302A patent/EP0324794B1/en not_active Expired - Lifetime
- 1987-11-06 WO PCT/DE1987/000507 patent/WO1988003803A1/en active IP Right Grant
- 1987-11-18 CN CN198787107852A patent/CN87107852A/en active Pending
-
1988
- 1988-07-08 DK DK198803858A patent/DK173353B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE72114T1 (en) | 1992-02-15 |
JPH02501304A (en) | 1990-05-10 |
JP2602043B2 (en) | 1997-04-23 |
DE3776574D1 (en) | 1992-03-12 |
AU622101B2 (en) | 1992-04-02 |
WO1988003803A1 (en) | 1988-06-02 |
EP0324794A1 (en) | 1989-07-26 |
DE3639418A1 (en) | 1988-06-09 |
DE3639418C2 (en) | 1989-08-03 |
DK173353B1 (en) | 2000-08-07 |
DE3645036A1 (en) | 1989-01-05 |
BR8707879A (en) | 1989-10-03 |
EP0324794B1 (en) | 1992-01-29 |
DK385888D0 (en) | 1988-07-08 |
CN87107852A (en) | 1988-06-22 |
DK385888A (en) | 1988-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8171287A (en) | Oral administration capsule with a nicotine-containing fluid medium | |
ES2033871T3 (en) | A PROCEDURE FOR PRODUCING AN INSULIN PREPARATION FOR PARENTERAL ADMINISTRATION. | |
CA2127253A1 (en) | Composition to help stop smoking | |
ES2009915A6 (en) | Pharmaceutical composition comprising cefuroxime axetil | |
AU581412B2 (en) | Tobacco product | |
DE69519300D1 (en) | STABLE MEDICINAL PRODUCT CONTAINING OXALIPLATINE | |
CA2063563A1 (en) | Means for use as an aid to stop smoking or for use in non-smoking areas | |
ES8303091A1 (en) | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration | |
IE882073L (en) | Pediatric ibuprofen formulations | |
MY100273A (en) | Improvements relating to smoking articles | |
AU6609490A (en) | Oral and dental hygiene preparation | |
ES2029942A6 (en) | Improvements relating to the processing of tobacco leaves. | |
JPS5771377A (en) | Sweetening agent having low cariogenicity | |
AU6977491A (en) | Smoking substitute | |
ES2010443A6 (en) | Make-your-own system for making a cigarette, especially a filter-tipped cigarette | |
GB1197174A (en) | Cigarettes | |
AU610515B2 (en) | Chocolate milk | |
EP0296116A3 (en) | Palatable edible oil compositions | |
JPS6413019A (en) | Aldose reductase inhibitor | |
USD270485S (en) | Cigar and cigarette filter perforator | |
ES398108A1 (en) | Pharmaceutical composition | |
JPS52108014A (en) | Artificial saliva | |
GB1336610A (en) | Antismoking chewing gum preparation | |
GB1372692A (en) | Cigarettes | |
GB1528786A (en) | Smoking composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |